Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 2
2018 8
2019 2
2020 5
2021 7
2022 11
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]-gingerol in cancer: A comprehensive review.
de Lima RMT, Dos Reis AC, de Menezes APM, Santos JVO, Filho JWGO, Ferreira JRO, de Alencar MVOB, da Mata AMOF, Khan IN, Islam A, Uddin SJ, Ali ES, Islam MT, Tripathi S, Mishra SK, Mubarak MS, Melo-Cavalcante AAC. de Lima RMT, et al. Among authors: khan in. Phytother Res. 2018 Oct;32(10):1885-1907. doi: 10.1002/ptr.6134. Epub 2018 Jul 16. Phytother Res. 2018. PMID: 30009484 Review.
COVID-19 Infection in Pregnancy: A Review.
Mily SJ, Akter KM, Jabin N, Mitra S, Emran TB, Nandi M, Baral SK, Uddin MZ, Mallick J, Paul A, Shah SUA, Rauf A, Khan IN, Mubarak MS. Mily SJ, et al. Among authors: khan in. Infect Disord Drug Targets. 2022;22(5):e050122199976. doi: 10.2174/1871526522666220105111358. Infect Disord Drug Targets. 2022. PMID: 34986776 Review.
HTLV-1 Associated Neurological Disorders.
Khan MY, Khan IN, Farman M, Al Karim S, Qadri I, Kamal MA, Al Ghamdi K, Harakeh S. Khan MY, et al. Curr Top Med Chem. 2017;17(12):1320-1330. doi: 10.2174/1568026616666161222141318. Curr Top Med Chem. 2017. PMID: 28017149 Review.
Nanomaterials multifunctional behavior for enlightened cancer therapeutics.
Raju GSR, Dariya B, Mungamuri SK, Chalikonda G, Kang SM, Khan IN, Sushma PS, Nagaraju GP, Pavitra E, Han YK. Raju GSR, et al. Among authors: khan in. Semin Cancer Biol. 2021 Feb;69:178-189. doi: 10.1016/j.semcancer.2019.08.013. Epub 2019 Aug 13. Semin Cancer Biol. 2021. PMID: 31419527 Review.
Health promoting benefits of pongamol: An overview.
Jahan S, Mahmud MH, Khan Z, Alam A, Khalil AA, Rauf A, Tareq AM, Nainu F, Tareq SM, Emran TB, Khan M, Khan IN, Wilairatana P, Mubarak MS. Jahan S, et al. Among authors: khan in. Biomed Pharmacother. 2021 Oct;142:112109. doi: 10.1016/j.biopha.2021.112109. Epub 2021 Aug 27. Biomed Pharmacother. 2021. PMID: 34470730 Free article. Review.
Anticancer Perspectives on the Fungal-Derived Polyphenolic Hispolon.
Islam MT, Ali ES, Khan IN, Shaw S, Uddin SJ, Rouf R, Dev S, Saravi SSS, Das N, Tripathi S, Yele SU, Das AK, Shilpi JA, Mishra SK, Mubarak MS. Islam MT, et al. Among authors: khan in. Anticancer Agents Med Chem. 2020;20(14):1636-1647. doi: 10.2174/1871520620666200619164947. Anticancer Agents Med Chem. 2020. PMID: 32560616 Review.
A Perspective on Emerging Therapeutic Interventions for COVID-19.
Torequl Islam M, Nasiruddin M, Khan IN, Mishra SK, Kudrat-E-Zahan M, Alam Riaz T, Ali ES, Rahman MS, Mubarak MS, Martorell M, Cho WC, Calina D, Docea AO, Sharifi-Rad J. Torequl Islam M, et al. Among authors: khan in. Front Public Health. 2020 Jul 3;8:281. doi: 10.3389/fpubh.2020.00281. eCollection 2020. Front Public Health. 2020. PMID: 32733837 Free PMC article. Review.
Nanoparticles in clinical trials of COVID-19: An update.
Rauf A, Abu-Izneid T, Khalil AA, Hafeez N, Olatunde A, Rahman M, Semwal P, Al-Awthan YS, Bahattab OS, Khan IN, Khan MA, Sharma R. Rauf A, et al. Among authors: khan in. Int J Surg. 2022 Aug;104:106818. doi: 10.1016/j.ijsu.2022.106818. Epub 2022 Aug 8. Int J Surg. 2022. PMID: 35953020 Free PMC article. Review.
Anticancer effects of acteoside: Mechanistic insights and therapeutic status.
Khan RA, Hossain R, Roy P, Jain D, Mohammad Saikat AS, Roy Shuvo AP, Akram M, Elbossaty WF, Khan IN, Painuli S, Semwal P, Rauf A, Islam MT, Khan H. Khan RA, et al. Among authors: khan in. Eur J Pharmacol. 2022 Feb 5;916:174699. doi: 10.1016/j.ejphar.2021.174699. Epub 2021 Dec 14. Eur J Pharmacol. 2022. PMID: 34919888 Review.
Recent advances and limitations of mTOR inhibitors in the treatment of cancer.
Ali ES, Mitra K, Akter S, Ramproshad S, Mondal B, Khan IN, Islam MT, Sharifi-Rad J, Calina D, Cho WC. Ali ES, et al. Among authors: khan in. Cancer Cell Int. 2022 Sep 15;22(1):284. doi: 10.1186/s12935-022-02706-8. Cancer Cell Int. 2022. PMID: 36109789 Free PMC article. Review.
33 results